Published: 23.01.2020
References:
- Voloshin P.V., Voloshina N.P., Taitslin V.I. et al. (2007) Multiple sclerosis in Ukraine: prevalence, course, prognosis, treatment, pharmacoeconomics. Ukr. Visn. psychoneurol., 15(50): 6–21.
- Voloshina N.P., Gritsay N.N., Dykan I.N. (2010) Multiple sclerosis: the urgency of the problem in Ukraine, modern aspects of immunopathogenesis, clinic, diagnosis and treatment. Konsp. Neurologist, 2: 30–51.
- State Statistics Service of Ukraine (2019) Population of Ukraine on January 1, 2019: Stat. Zb. Kiev, 83 p.
- Mishchenko T.S., Shulga O.D., Bobrik N.V., Shulga L.A. (2014) Multiple sclerosis: a global perspective. UMJ, 3(101): 84–87.
- Pazhigova Z.B., Karpov S.M., Shevchenko P.P., Burnusus N.I. (2014) The prevalence of multiple sclerosis in the world (review article). J. Exp. Educ., 1–2: 78–82.
- Alla S., Pearson J.F., Taylor B.V. et al. (2016) An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand. Mult. Scler., 22(5): 705–707, doi: 10.1177/1352458515605909.
- Becuş T., Popoviciu L. (1994) Epidemiologic survey of multiple sclerosis in Mureş County, Romania. Rom. J. Neurol. Psychiatry, 32(2): 115–122.
- Berg-Hansen P., Moen S.M., Sandvik L. et al. (2015) Prevalence of multiple sclerosis among immigrants in Norway. Mult. Scler., 21(6): 695–702, doi: 10.1177/1352458514554055.
- Brola W., Sobolewski P., Flaga S. et al. (2017) Increasing prevalence and incidence of multiple sclerosis in Poland. Neurol. Neurochir. Pol., 51(1): 82–85, doi: 10.1016/j.pjnns.2016.11.005.
- Dobson R., Ramagopalan S., Davis A., Giovannoni G. (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J. Neurol. Neurosurg. Psychiatry, 84(8): 909–914, doi: 10.1136/jnnp-2012-304695.
- Eskandarieh S., Heydarpour P., Minagar A. et al. (2016) Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review. Neuroepidemiology, 46(3): 209–221, doi: 10.1159/000444019.
- Etemadifar M., Mehrabi B., Kiani-Peykani R. et al. (2016) Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran. Acta Neurol. Scand., 134(4): 292–299, doi: 10.1111/ane.12543.
- Häsänen E., Kinnunen E., Alhonen P. (1986) Relationships between the prevalence of multiple sclerosis and some physical and chemical properties of soil. The Science of the total environment, 58(3): 263–272, doi: 10.1016/0048-9697(86)90206-8.
- Kurtzke J.F. (1975) A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol. Scandinav., 51(2): 110–136, doi: 10.1111/j.1600-0404.1975.tb01364.x.
- Lonergan R., Kinsella K., Fitzpatrick P. et al. (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J. Neurol. Neurosurg. Psychiatr., 82(3): 317–322, doi: 10.1136/jnnp.2010.220988.
- Marcoci C., Lisnic V., Gavriliuc M. et al. (2016) Prevalence of multiple sclerosis in the republic of Moldova. Neuroepidemiology, 46(3): 166–172, doi: 10.1159/000443931.
- Nakamura Y., Matsushita T., Sato S. et al.; Japan Multiple Sclerosis Genetics Consortium (2016) Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study. J. Neuroinflammation, 13(1): 239, doi: 10.1186/s12974-016-0695-3.
- Pivot D., Debouverie M., Grzebyk M. et al. (2016) Geographical heterogeneity of multiple sclerosis prevalence in France. PloS One, 11(12): e0167556, doi: 10.1371/journal.pone.0167556.
- Spelman T., Gray O., Trojano M. et al. (2014) Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Ann. Neurol., 76(6): 880–890, doi: 10.1002/ana.24287.
- Tao C., Simpson S.Jr., van der Mei I. et al.; MSBase Study Group (2016) Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr., 87(12): 1343–1349, doi: 10.1136/jnnp-2016-314013.
- Thompson A.J., Banwell B.L., Barkhof F. et al. (2018a) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol., 17(2): 162–173. doi: 10.1016/S1474-4422(17)30470-2.
- Thompson A.J., Baranzini S.E., Geurts J. et al. (2018b) Multiple sclerosis. Lancet, 391(10130): 1622–1636, doi: 10.1016/S0140-6736(18)30481-1.
- Tsai C.P., Lee C.T. (2013) Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan. PloS One, 8(6): e65911, doi: 10.1371/journal.pone.0065911.
- Zeman D., Kušnierová P., Hradílek P. (2019) Roztroušená skleróza: likvorové biomarkery zánětu a tkáňového poškození. Sympozium Dialog, Valeč, 72 p.